Miragen Therapeutics Inc Revenue Growth Rates (MGEN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Miragen Therapeutics Inc   (NASDAQ: MGEN)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

MGEN's Revenue Growth by Quarter and Year

Miragen Therapeutics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/MGEN/growth
https://api.csimarket.com/api/v1/companies/MGEN/fundamentals
https://api.csimarket.com/api/v1/companies/MGEN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
MGEN Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December -
3rd Quarter September 25.75
2nd Quarter June 0.28
1st Quarter March 0.08
FY 26.11

MGENs Annual Revenue
Miragen Therapeutics Inc 's Revenue in the fiscal year 2019 $ 4.46 millions
Miragen Therapeutics Inc 's Revenue in the fiscal year 2018 $ 8.39 millions
Miragen Therapeutics Inc 's Revenue in the fiscal year 2017 $ 4.00 millions
Miragen Therapeutics Inc 's Revenue in the fiscal year 2016 $ 3.34 millions
Miragen Therapeutics Inc 's Revenue in the fiscal year 2015 $ 2.54 millions




MGEN Revenue third quarter 2020 Y/Y Growth Comment
Miragen Therapeutics Inc achieved in the third quarter 2020, above Company average Revenue surge of 15048.24% year on year, to $ 25.75 millions.

Looking into third quarter 2020 results within Medical Laboratories industry 15 other companies have achieved higher Revenue growth. While Miragen Therapeutics Inc ' s Revenue doubling of 15048.24% ranks overall at the positon no. 1221 in the third quarter 2020.


MGEN Revenue ( Y/Y Growth %) 2020
 FY 2019 FY 2018 FY 2017
4th Quarter December -
3rd Quarter September 15048.24 %
2nd Quarter June -68.18 %
1st Quarter March -88.57 %
FY   -

Financial Statements
Miragen Therapeutics Inc 's third quarter 2020 Revenue $ 25.75 millions MGEN's Income Statement
Miragen Therapeutics Inc 's third quarter 2019 Revenue $ 0.17 millions Quarterly MGEN's Income Statement


MGEN Revenue (Quarter on Quarter Growth %)

 2020
 FY 2019 FY 2018 FY 2017
4th Quarter December -
3rd Quarter September 9097.14 %
2nd Quarter June 250 %
1st Quarter March -
FY (Year on Year)   -


Back to MGEN Growth rate Comparisons >> Back to MGEN Growth rate Comparisons >>


Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #16
Healthcare Sector #250
Overall #1221

Revenue Y/Y Growth Statistics
High Average Low
279.71 % 20.45 % -56.27 %
(Jun 30 2018)   (Dec 31 2015)
Revenue third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #16
Healthcare Sector #250
Overall #1221
Revenue Y/Y Growth Statistics
High Average Low
279.71 % 20.45 % -56.27 %
(Jun 30 2018)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Miragen Therapeutics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
575.81 % 26.95 % -100 %
(Jun 30 2019)  


MGEN's III. Quarter Q/Q Revenue Comment
Miragen Therapeutics Inc achieved in the III. Quarter 2020 above company average sequential Revenue doubling of 9097.14%, to $ 25.75 millions, from $0.28 millions in the second quarter.
MGEN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry Miragen Therapeutics Inc achieved highest sequential Revenue growth. While Miragen Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 121.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #44
Overall #121
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #0
Healthcare Sector #44
Overall #121
Revenue Q/Q Growth Statistics
High Average Low
575.81 % 26.95 % -100 %
(Jun 30 2019)  


MGEN's III. Quarter Q/Q Revenue Comment
Miragen Therapeutics Inc achieved in the III. Quarter 2020 above company average sequential Revenue doubling of 9097.14%, to $ 25.75 millions, from $0.28 millions in the second quarter.
MGEN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Laboratories industry Miragen Therapeutics Inc achieved highest sequential Revenue growth. While Miragen Therapeutics Inc 's Revenue growth quarter on quarter, overall rank is 121.


Miragen Therapeutics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2020)		 12 Months Ending (Jun 30 2020) 12 Months Ending (Dec 31 2019) 12 Months Ending (Sep 30 2019) 12 Months Ending (Jun 30 2019)
Cumulative Revenue 12 Months Ending $ 0.00
Y / Y Revenue Growth (TTM) -
Year on Year Revenue Growth Overall Ranking # 3928
Seqeuential Revenue Change (TTM) -
Seq. Revenue Growth (TTM) Overall Ranking # 1221


Cumulative Revenue growth Comment
Miragen Therapeutics Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2020, compare to Revenue of $ 4 millions a year ago.

In the Healthcare sector 550 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3518 to 3928.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 16
Healthcare Sector # 551
Overall # 3928

Revenue TTM Y/Y Growth Statistics
High Average Low
279.71 %
 20.45 %
-56.27 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 250
S&P 500 # 1221
Cumulative Revenue growth Comment
Miragen Therapeutics Inc realized trailing twelve months of $ 0 millions, in the Sep 30 2020, compare to Revenue of $ 4 millions a year ago.

In the Healthcare sector 550 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 3518 to 3928.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 16
Healthcare Sector # 551
Overall # 3928

Revenue TTM Y/Y Growth Statistics
High Average Low
279.71 %
20.45 %
-56.27 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 16
Sector # 250
S&P 500 # 1221




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MGEN's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue doubling for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Viskase Holdings inc 19,109.48%$ 19,109.476 millions


About Miragen Therapeutics Inc Revenue Growth Rates (MGEN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.